Last reviewed · How we verify
FLUOROCHOLINE
At a glance
| Generic name | FLUOROCHOLINE |
|---|---|
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors (PHASE2, PHASE3)
- Choline-PET: Exploratory Study Assessing the Potential Role of F-choline PET Imaging in New and Emerging Indications (PHASE3)
- Interest of Trimodality PET-CT Choline MRI Before Radiotherapy in High Risk Prostate Cancer (NA)
- Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas
- 99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT (PHASE2, PHASE3)
- 18F-choline Positron-emission-tomography - Computed-tomography Compared to Conventional Imaging for Localizing Diseased Parathyroid Glands in Primary Hyperparathyroidism (NA)
- Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma (PHASE3)
- Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FLUOROCHOLINE CI brief — competitive landscape report
- FLUOROCHOLINE updates RSS · CI watch RSS